XORTX Therapeutics Inc. (XRTX) Financials
XRTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 4.9 million | 407458 |
| June 30, 2023 | 5.9 million | 304623 |
| March 31, 2023 | 12.4 million | 5.4 million |
| Dec. 31, 2022 | 12.4 million | 5.4 million |
XRTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -793216 | 16077 |
| June 30, 2023 | -1.3 million | 23242 |
| March 31, 2023 | -3.8 million | 71140 |
| Dec. 31, 2022 | -3.8 million | 70978 |
XRTX Net Income
No data available :(
XRTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 3.7 million | - | 20979 |
| June 30, 2023 | 4.7 million | - | 34132 |
| March 31, 2023 | 10.4 million | - | 45484 |
| Dec. 31, 2022 | 10.4 million | - | 77510 |
XRTX Shares Outstanding
XRTX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | 5370 | 419199 | 375342 | - |
| June 30, 2023 | 7205 | 504541 | 545627 | - |
| March 31, 2023 | 16024 | 1.9 million | 514587 | - |
| Dec. 31, 2022 | 15988 | 1.9 million | 513411 | - |
XRTX Cost of Revenue
No data available :(
XRTX
Price: $1.76
52 week price:
Dividend Yield: 14.08%
Earnings Per Share: -0.40 USD
P/E Ratio: -1.01
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 45600
Market Capitalization: 477386